LOC729176 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.847600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.535000E-01
Normal-vs-Stage2
5.149400E-01
Normal-vs-Stage3
2.686300E-02
Normal-vs-Stage4
9.590200E-01
Stage1-vs-Stage2
9.501800E-01
Stage1-vs-Stage3
5.165000E-01
Stage1-vs-Stage4
6.927200E-01
Stage2-vs-Stage3
4.144200E-01
Stage2-vs-Stage4
6.913400E-01
Stage3-vs-Stage4
4.649800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.565400E-01
Normal-vs-AfricanAmerican
9.554000E-01
Normal-vs-Asian
5.852600E-01
Caucasian-vs-AfricanAmerican
3.435400E-01
Caucasian-vs-Asian
9.210200E-01
AfricanAmerican-vs-Asian
5.401400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.780200E-01
Normal-vs-Female
6.428200E-01
Male-vs-Female
1.368580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.151200E-01
Normal-vs-Age(41-60Yrs)
7.981000E-01
Normal-vs-Age(61-80Yrs)
3.688600E-01
Normal-vs-Age(81-100Yrs)
3.868200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.609600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.485200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.500600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.545500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.965600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.054200E-01
Normal-vs-Daily Drinker
1.959210E-01
Normal-vs-Weekly Drinker
9.478200E-02
Normal-vs-Occasional Drinker
6.952000E-01
Normal-vs-Social Drinker
4.440800E-01
Non Drinker-vs-Daily Drinker
6.067200E-01
Non Drinker-vs-Weekly Drinker
4.015400E-01
Non Drinker-vs-Occasional Drinker
9.710400E-02
Non Drinker-vs-Social Drinker
5.965000E-01
Daily Drinker-vs-Weekly Drinker
7.596400E-01
Daily Drinker-vs-Occasional Drinker
6.437800E-02
Daily Drinker-vs-Social Drinker
3.996000E-01
Weekly Drinker-vs-Occasional Drinker
3.613800E-02
Weekly Drinker-vs-Social Drinker
2.798800E-01
Occasional Drinker-vs-Social Drinker
4.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.731800E-02
Normal-vs-Grade 2
7.817600E-03
Normal-vs-Grade 3
1.884180E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.113000E-01
Grade 1-vs-Grade 3
3.666200E-01
Grade 1-vs-Grade 4
7.731800E-02
Grade 2-vs-Grade 3
9.010400E-01
Grade 2-vs-Grade 4
7.817600E-03
Grade 3-vs-Grade 4
1.884180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.154200E-01
Normal-vs-NonDiabetic
4.474200E-01
Diabetic-vs-NonDiabetic
3.605800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.562900E-03
Normal-vs-NoPancreatitis
4.279600E-01
Pancreatitis-vs-NoPancreatitis
1.010140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.701400E-01
Normal-vs-N1
5.218400E-01
N0-vs-N1
5.751400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.932400E-01
Normal-vs-TP53-NonMutant
3.552000E-01
TP53-Mutant-vs-TP53-NonMutant
9.780500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
